Nutriband Inc. (NTRB)
NASDAQ·Healthcare·Biotechnology
$3.89
-0.08%
Mkt Cap $51.74M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q4 2025 Dec 16, 2025 | $675.00K | $346.06K | -48.73% | -$2.13 | -$0.12 | +94.37% | — | — |
| Q3 2025 Sep 9, 2025 | $675.00K | $622.45K | -7.78% | -$0.17 | -$2.12 | -1147.06% | — | — |
| Q2 2025 May 30, 2025 | $705.00K | $667.43K | -5.33% | -$0.13 | -$0.12 | +7.69% | — | — |
| Q2 2025 Apr 28, 2025 | $710.00K | $642.38K | -9.52% | -$0.12 | -$0.18 | -50.00% | — | — |
| Q4 2024 Dec 3, 2024 | — | $645.80K | — | — | -$0.12 | — | — | — |
| Q3 2024 Sep 3, 2024 | — | $442.83K | — | — | -$0.12 | — | — | — |
| Q2 2024 May 31, 2024 | — | $408.53K | — | — | -$0.21 | — | — | — |
| Q2 2024 Apr 30, 2024 | — | $524.61K | — | — | -$0.16 | — | — | — |
| Q4 2023 Dec 12, 2023 | — | $427.84K | — | — | -$0.22 | — | — | — |
| Q3 2023 Sep 11, 2023 | — | $655.93K | — | — | -$0.11 | — | — | — |
| Q2 2023 Jun 9, 2023 | — | $476.93K | — | — | -$0.13 | — | — | — |
| Q2 2023 Apr 26, 2023 | $675.00K | $527.53K | -21.85% | -$0.05 | -$0.21 | -320.00% | — | — |
| Q4 2022 Dec 2, 2022 | $563.16K | $618.00K | +9.74% | -$0.07 | -$0.14 | -100.00% | — | — |
| Q3 2022 Sep 7, 2022 | $456.10K | $456.15K | +0.01% | -$0.07 | -$0.12 | -71.43% | — | — |
| Q2 2022 May 31, 2022 | $477.91K | $477.92K | +0.00% | -$0.06 | -$0.08 | -33.33% | — | — |
| Q2 2022 Apr 29, 2022 | $455.76K | $491.89K | +7.93% | -$0.09 | -$0.20 | -122.22% | — | — |
| Q4 2021 Dec 14, 2021 | $890.00K | $283.04K | -68.20% | -$0.03 | -$0.23 | -574.88% | — | — |
| Q3 2021 Sep 3, 2021 | $1.92M | $213.74K | -88.89% | -$0.01 | -$0.07 | -900.00% | — | — |
| Q2 2021 Jun 14, 2021 | — | $433.49K | — | — | -$0.04 | — | — | — |
| Q2 2021 Apr 2, 2021 | — | $348.09K | — | — | -$0.33 | — | — | — |